Reversal Agents for the Management of Direct Oral Anticoagulant-Related Bleeding in Cardiac Surgical Patients: The Emperor's New Clothes?

J Cardiothorac Vasc Anesth. 2021 Aug;35(8):2480-2482. doi: 10.1053/j.jvca.2021.04.007. Epub 2021 Apr 11.

Authors

M Charlesworth¹, T Hayes¹, G Erdoes²

Affiliations

¹ Department of Cardiothoracic Anaesthesia, Critical Care and ECMO, Wythenshawe Hospital, Manchester University NHS Foundation Trust, Manchester, UK.
² Adult and Paediatric Cardiovascular Anaesthesia, Department of Anaesthesiology and Pain Medicine, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.

PMID: 33985882
DOI: 10.1053/j.jvca.2021.04.007

No abstract available

Publication types

Editorial
Comment

MeSH terms

Anticoagulants* / adverse effects
Cardiac Surgical Procedures* / adverse effects
Heart
Hemorrhage
Humans

Substances

Anticoagulants